Abstract
Aims
A study was designed to assess the effects of a standardized instructional videotape on reducing interobserver variability for several commonly used observer-dependent outcome measures.
Methods
During a single day, six rheumatologists independently examined six patients with fibromyalgia (FM) in a predetermined order using a Latin square design, before and after viewing a standardized videotape which demonstrated methods for performing dolorimetry and for detecting skinfold tenderness and reactive hyperaemia. Reliability coefficients were calculated based on the variance components of the analysis of variance (ANOVA) table.
Results
Prestandardization reliability coefficients were <0.80 for 8 measures. Following standardization all reliability coefficients approximated to or exceeded 0.80.
Conclusions
An important and beneficial effect of the standardization procedure was noted for several outcome variables. Such reductions in observer variability have the potential to diminish sample size requirements for FM antirheumatic drug studies. The use of a videotape to achieve this goal has obvious cost and convenience advantages over one-on-one training procedures.
Similar content being viewed by others
References
Bellamy N, Anastassiades TP, Buchanan WW et al. Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol. 1991;18:1893–1900.
Bellamy N, Carette S, Ford PM et al. Osteoarthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol. 1992;19:436–43.
Bellamy N, Buchanan WW, Esdaile JM et al. Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol. 1991;18:1701–8.
Bellamy N, Bell MJ, Carette S et al. Estimation of observer reliability and sample size calculation parameters for outcome measures in fibromyalgia clinical trials. Inflammopharmacology. 1994;2:345–60.
White KP, Harth M. An analytical review of 24 controlled clinical trials for fibromyalgia syndrome (FMS). Pain. 1996;64:211–9.
Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–72.
Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992;35:498–502.
Box GEP, Hunter WG, Hunter JS. Statistics for Experimenters. New York: John Wiley; 1978.
SAS Users Guide: Basics and Statistics, Version 5 edition. Cary: SAS Institute Inc.; 1985.
Van der Heijde D, Bellamy N, Calin A, Dougados M, Khan A, van der Linden S, and The ASAS Working Group. Preliminary core sets for efficacy endpoints in ankylosing spondylitis. J Rheumatol. 1997 [In press].
Felson DT, Anderson JJ, Boers M et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum. 1993;36:729–40.
Altman R, Brandt K, Hochberg M et al. Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society. Osteoarthritis Cart. 1996;4:217–43.
Simms RW, Felson DT, Goldenberg DL. Development of preliminary criteria for response to treatment in fibromyalgia syndrome. J Rheumatol. 1991;18:1558–63.
Bellamy N. Musculoskeletal Clinical Metrology. Dordrecht: Kluwer Academic Publishers; 1993:185–7.
Bellamy N, Muirden KD, Brooks P, Barroclough D, Tellus MM, Campbell J. A survey of outcome measurement procedures used in routine rheumatology outpatient practice by Australian rheumatologists. Scientific Program of the Australian Rheumatology Association 40th Annual Scientific Conference, Brisbane. May 25–28, 1997, p. 160.
Bellamy N, Kaloni S, Pope J, Coulter K, Campbell J. A survey of outcome measurement procedures used in routine rheumatology outpatient practice by Canadian rheumatologists. Canadian Rheumatology Association Annual Meeting, Mont-Tremblant, Quebec. February 27–March 1. J Rheumatol. 1997;24:1425.
Bellamy N. Musculoskeletal Clinical Metrology. Dordrecht: Kluwer Academic Publishers; 1993;348:356–7.
Klinkoff AV, Bellamy N, Bombardier C et al. An experiment in reducing interobserver variability of the examination for joint tenderness. J Rheumatol. 1988;15:492–4.
Bellamy N, Muirden KD, Bendrups A et al. Effect of a standardized videotape on observer dependent outcome measures in rheumatoid arthritis. Scientific Program of the Australian Rheumatology Association 40th Annual Scientific Conference, Brisbane. May 25–28, 1997, p. 161.
Bellamy N, Bachmeier C, Brooks P et al. Effect of a standardized videotape on observer-dependent outcome measures in osteoarthritis. Scientific Program of the Australian Rheumatology Association 40th Annual Scientific Conference, Brisbane. May 25–28, 1997, p. 162.
Bellamy N, Muirden KD, Boyden K et al. Effect of a standardized videotape on observer dependent outcome measures in ankylosing spondylitis. Scientific Program of the Australian Rheumatology Association 40th Annual Scientific Conference, Brisbane. May 25–28, 1997, p. 159.
Pope JE, Baron M, Bellamy N et al. Variability of skin scores and clinical measurements in scleroderma. J Rheumatol. 1995;22:1271–6.
Green S, Buchbinder R, Forbes A, Bellamy N. A standardized protocol for measurement of range of movement of the shoulder using the plurimeter-V inclinometer and assessment of its intrarater and interrater reliability. Arthritis Care Res. 1997 (Submitted).
Bellamy N. Musculoskeletal Clinical Metrology. Dordrecht: Kluwer Academic Publishers; 1993:11–24.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bellamy, N., Buchbinder, R., Hall, S. et al. Fibromyalgia antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent outcome measures. Inflammopharmacol 5, 261–272 (1997). https://doi.org/10.1007/s10787-997-0004-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10787-997-0004-y